U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Ovarian Seromucinous Carcinoma

MedGen UID:
1791613
•Concept ID:
C5555172
•
Neoplastic Process

Definition

The reemergence of ovarian seromucinous carcinoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Ovarian Seromucinous Carcinoma

Professional guidelines

PubMed

Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW, Riopel MA, Smith Sehdev AE, Ronnett BM, Kurman RJ
Am J Surg Pathol 2002 Dec;26(12):1529-41. doi: 10.1097/00000478-200212000-00001. PMID: 12459620

Recent clinical studies

Etiology

Mixed Ovarian Neoplasms With Gastrointestinal-type Mucinous and Mullerian Epithelial Components: A Rare Group of Tumors Demonstrating the Phenotypic Plasticity of the Mullerian Epithelial Cell.
Chui MH, Ellenson LH
Am J Surg Pathol 2023 Jul 1;47(7):756-765. Epub 2023 May 1 doi: 10.1097/PAS.0000000000002045. PMID: 37125505Free PMC Article
PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis.
Yun BS, Won S, Kim JH, Lee N, Kim M, Kim MK, Kim ML, Jung YW, Kim JY, Seong SJ, Shin E
J Ovarian Res 2022 Apr 6;15(1):41. doi: 10.1186/s13048-022-00975-5. PMID: 35387670Free PMC Article
Survival and reproductive outcomes after fertility-sparing surgery performed for borderline epithelial ovarian tumor in Japanese adolescents and young adults: Results of a retrospective nationwide study.
Kuji S, Harada M, Yoshioka N, Kajiyama H, Satoh T, Mikami M, Shozu M, Enomoto T, Osuga Y, Suzuki N
J Obstet Gynaecol Res 2022 Mar;48(3):806-816. Epub 2021 Dec 23 doi: 10.1111/jog.15131. PMID: 34951514
Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis.
Hada T, Miyamoto M, Ishibashi H, Matsuura H, Sakamoto T, Kakimoto S, Iwahashi H, Suzuki R, Sato K, Tsuda H, Takano M
Medicine (Baltimore) 2021 Aug 13;100(32):e26895. doi: 10.1097/MD.0000000000026895. PMID: 34397915Free PMC Article
Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW, Riopel MA, Smith Sehdev AE, Ronnett BM, Kurman RJ
Am J Surg Pathol 2002 Dec;26(12):1529-41. doi: 10.1097/00000478-200212000-00001. PMID: 12459620

Diagnosis

Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED, Marques-Piubelli ML, Ramalingam P, Wistuba I, Lawson BC, Frumovitz M, Malpica A
Am J Surg Pathol 2023 Jun 1;47(6):635-648. Epub 2023 Apr 6 doi: 10.1097/PAS.0000000000002039. PMID: 37026792
Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis.
Hada T, Miyamoto M, Ishibashi H, Matsuura H, Sakamoto T, Kakimoto S, Iwahashi H, Suzuki R, Sato K, Tsuda H, Takano M
Medicine (Baltimore) 2021 Aug 13;100(32):e26895. doi: 10.1097/MD.0000000000026895. PMID: 34397915Free PMC Article
Synchronous Occurrence of Ovarian Seromucinous Carcinoma and Endometrial Mucinous Carcinoma: A Case Report.
Urakawa R, Harada H, Tohyama A, Aoyama Y, Kinjo Y, Hoshino K, Ueda T, Kagami S, Tsukamoto J, Aoki T, Iwamura R, Hisaoka M, Matsuura Y, Yoshino K
J UOEH 2021;43(2):235-242. doi: 10.7888/juoeh.43.235. PMID: 34092768
Anaplastic carcinoma in ovarian seromucinous cystic tumor of borderline malignancy.
Okumura T, Muronosono E, Tsubuku M, Terao Y, Takeda S, Maruyama M
J Ovarian Res 2018 Sep 3;11(1):77. doi: 10.1186/s13048-018-0449-1. PMID: 30176911Free PMC Article
Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF, McIntyre JB, Taylor J, Lee S, Ogilvie T, Sienko A, Morris D, Duggan MA, McCluggage WG, Köbel M
Am J Surg Pathol 2017 May;41(5):685-695. doi: 10.1097/PAS.0000000000000812. PMID: 28125452

Therapy

Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF, McIntyre JB, Taylor J, Lee S, Ogilvie T, Sienko A, Morris D, Duggan MA, McCluggage WG, Köbel M
Am J Surg Pathol 2017 May;41(5):685-695. doi: 10.1097/PAS.0000000000000812. PMID: 28125452
The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer.
Drisko JA, Chapman J, Hunter VJ
J Am Coll Nutr 2003 Apr;22(2):118-23. doi: 10.1080/07315724.2003.10719284. PMID: 12672707

Prognosis

Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED, Marques-Piubelli ML, Ramalingam P, Wistuba I, Lawson BC, Frumovitz M, Malpica A
Am J Surg Pathol 2023 Jun 1;47(6):635-648. Epub 2023 Apr 6 doi: 10.1097/PAS.0000000000002039. PMID: 37026792
Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis.
Hada T, Miyamoto M, Ishibashi H, Matsuura H, Sakamoto T, Kakimoto S, Iwahashi H, Suzuki R, Sato K, Tsuda H, Takano M
Medicine (Baltimore) 2021 Aug 13;100(32):e26895. doi: 10.1097/MD.0000000000026895. PMID: 34397915Free PMC Article
Synchronous Occurrence of Ovarian Seromucinous Carcinoma and Endometrial Mucinous Carcinoma: A Case Report.
Urakawa R, Harada H, Tohyama A, Aoyama Y, Kinjo Y, Hoshino K, Ueda T, Kagami S, Tsukamoto J, Aoki T, Iwamura R, Hisaoka M, Matsuura Y, Yoshino K
J UOEH 2021;43(2):235-242. doi: 10.7888/juoeh.43.235. PMID: 34092768
Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF, McIntyre JB, Taylor J, Lee S, Ogilvie T, Sienko A, Morris D, Duggan MA, McCluggage WG, Köbel M
Am J Surg Pathol 2017 May;41(5):685-695. doi: 10.1097/PAS.0000000000000812. PMID: 28125452
Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Shappell HW, Riopel MA, Smith Sehdev AE, Ronnett BM, Kurman RJ
Am J Surg Pathol 2002 Dec;26(12):1529-41. doi: 10.1097/00000478-200212000-00001. PMID: 12459620

Clinical prediction guides

Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED, Marques-Piubelli ML, Ramalingam P, Wistuba I, Lawson BC, Frumovitz M, Malpica A
Am J Surg Pathol 2023 Jun 1;47(6):635-648. Epub 2023 Apr 6 doi: 10.1097/PAS.0000000000002039. PMID: 37026792
Survival and reproductive outcomes after fertility-sparing surgery performed for borderline epithelial ovarian tumor in Japanese adolescents and young adults: Results of a retrospective nationwide study.
Kuji S, Harada M, Yoshioka N, Kajiyama H, Satoh T, Mikami M, Shozu M, Enomoto T, Osuga Y, Suzuki N
J Obstet Gynaecol Res 2022 Mar;48(3):806-816. Epub 2021 Dec 23 doi: 10.1111/jog.15131. PMID: 34951514
Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF, McIntyre JB, Taylor J, Lee S, Ogilvie T, Sienko A, Morris D, Duggan MA, McCluggage WG, Köbel M
Am J Surg Pathol 2017 May;41(5):685-695. doi: 10.1097/PAS.0000000000000812. PMID: 28125452

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...